UNSPSC 51352201: Benzestrol

This classification denotes a therapeutic estrogen with the molecular formula C20H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A27512LR47, chemically known as 4,4-(1,2-diethyl-3-methyltrimethylene)diphenol but generally known as benzestrol, which bears US NIH Compound Identifier 6827. European Medicines Agency schedules Benzestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05744MIG. The term BENZESTROL is an International Non-Proprietary Name.

UNSPSC 51352201 Benzestrol is a Commodity code that covers generic pharmaceutical products supplied through multistate cooperative purchasing agreements to state and local government healthcare facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary recent issuing body under this code, establishing blanket contracts that serve participating state agencies, counties, municipalities, and healthcare systems across multiple jurisdictions including Oregon. The work involves manufacturing and supplying generic multi-source pharmaceuticals and over-the-counter products with specified National Drug Codes (NDC), SKUs, UPCs, and packaging configurations to authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) for distribution across participating facilities. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place, and carry comprehensive insurance including $5,000,000 commercial general liability coverage per occurrence.

MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802) was posted January 20, 2026, with proposals due March 26, 2026. The evaluation emphasizes price competitiveness (75 percent of the score), with secondary weight given to fixed pricing structure (10 percent), compliance with administrative data formatting and EDI capability (5 percent each), and agreement to a 3 percent administrative fee (5 percent). Awarded vendors will be active through July 1, 2026, with a two-year initial contract term and optional extensions at MMCAP's discretion, and all products must be available in the marketplace by May 15, 2026, with minimum six-month shelf life and at least one year remaining expiration date from manufacture. No specific dollar values or set-aside designations were disclosed in the available documentation.